Nestle Cookie Dough Recall and New E. coli Discovery Lead to New Formula

Nestle USA has announced that it will change the formula for its famous Toll House raw cookie dough products after two recent samples tested positive for E. coli bacteria. The same products were part of a massive cookie dough recall last summer, which was linked to cases of food poisoning in people from at least 30 states.

The company indicated on Monday that E. coli bacteria was found in additional samples of Nestle Toll House refrigerated and prepackaged cookie dough products before they were shipped. As a result, the company shut down production at their Danville, Virginia, plant to switch to a new formula that uses heat-treated flour.

The plant is scheduled to re-open on January 25. Nestle officials said that none of the packages from the contaminated batch left the factory, so there is no need for another Toll House raw cookie dough recall, and products that are on the shelf were reportedly not affected.

Did You Know?

Ticketmaster Data Breach Impacts Millions of Customers

A massive Ticketmaster data breach exposed the names, addresses, phone numbers, credit card numbers and other personal information of more than 560 million customers, which have now been released on the dark web. Lawsuits are being pursued to obtain financial compensation.

Learn More

All Nestle Toll House refrigerated and prepackaged cookie dough products were recalled on June 19, 2009, when at least 69 people reportedly suffered E. coli food poisoning after eating the Nestle cookie dough raw. Nine of those cases resulted in hemolytic uremic syndrome (HUS), a severe form of food poisoning associated with kidney failure.

After the food poisoning outbreak, the factory was shut down for an extensive period while the company and FDA inspectors searched the plant for the source of the contamination. No cause for the outbreak was ever found, but the plant instituted new testing standards that included testing of all ingredients before they entered the factory and testing of products before they shipped out.

Several cookie dough food poisoning lawsuits have been filed against Nestle as a result of the E. coli outbreak, which mostly affected teen and pre-teen girls. Symptoms of E. coli food poisoning could include bloody diarrhea and abdominal cramps. While most people recovered in about a week, young children, the elderly and those with a weak immune system were more susceptible to severe infections.

0 Comments

Share Your Comments

I authorize the above comments be posted on this page*

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

This field is for validation purposes and should be left unchanged.

More Top Stories

Ozempic MDL Court To Evaluate Need for Gastroparesis Diagnostic Testing in GLP-1 Lawsuits
Ozempic MDL Court To Evaluate Need for Gastroparesis Diagnostic Testing in GLP-1 Lawsuits (Posted 2 days ago)

A federal judge has agreed to divide lawsuits over gastroparesis injuries linked to drugs like Ozempic and Mounjaro into multiple phases, examining how the condition is diagnosed and whether plaintiffs' claims are preempted by federal laws.

Adult Woman Files Similac Lawsuit Over NEC Injuries Experienced as a Newborn
Adult Woman Files Similac Lawsuit Over NEC Injuries Experienced as a Newborn (Posted 3 days ago)

Lawsuit alleges that Abbott Laboratories failed to provide families and the medical community with adequate warnings about the risks associated with it’s cow’s milk-based Similac formula, which a now adult woman indicates has left her with life-long NEC injuries.

Amended Lawsuit Over BioZorb Implant Side Effects Outlines Problems Caused By Tissue Marker Design Defects
Amended Lawsuit Over BioZorb Implant Side Effects Outlines Problems Caused By Tissue Marker Design Defects (Posted 4 days ago)

Six breast cancer patients have asked a federal judge for permission to amend a complaint filed in March 2024, which describes problems linked to the device and painful side effects experienced when the tissue marker migrated out of position or shattered inside their bodies.